RIGATONI- MLHP news not shabby!: MMH Malarex(TM) Yields Positive Results in Comparative Study Against an Established Anti-Malaria Drug
Thursday March 4, 8:32 am ET
MONTREAL, March 4 /PRNewswire-FirstCall/ -- Millenia Hope Inc., a Biotech Corporation (OTC Bulletin Board: MLHP - News; Berlin: MLF - News), stated that the results of a comparative test involving Millenia's MMH Malarex(TM), an all natural anti-malarial agent with no parasitic resistance, and Camoquine, a chloroquine based anti-malarial, were positive.
The test run in the African nation of Cameroon, involved 102 patients and was conducted under the supervision of Professor Same Ekobo, Chief of the Parasitology Department of the Faculty of Medicine and Biosciences at the University of Yaounde, Cameroon. The full text of the test results will be published in a peer reviewed scientific journal.
